Standard Contracts
INDICATES CONFIDENTIAL PORTION HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION MASTER MANUFACTURING AND SUPPLY AGREEMENTMaster Manufacturing and Supply Agreement • August 14th, 2015 • Oasmia Pharmaceutical AB • Pharmaceutical preparations
This MASTER MANUFACTURING Supply Agreement (this “Agreement”) is made effective as of the 25th day of April, 2014 (“Effective Date”) by and between Baxter Oncology GmbH, with an address at Kantstrasse 2, 33790 Halle / Westphalia, Germany, as such term is defined herein (“Baxter”) and OASMIA PHARMACEUTICAL AB, a Swedish corporation, having offices at Vallongatan 1, SE 752 28 Uppsala Sweden (“Client” or “Oasmia”).
EX-10.14 4 d381653dex1014.htm MASTER MANUFACTURING AND SUPPLY AGREEMENT (PFIZER AS MANUFACTURER) MASTER MANUFACTURING AND SUPPLY AGREEMENT BETWEEN PFIZER INC. AND ZOETIS INC. DATED AS OF OCTOBER 1, 2012 Exhibits: Exhibit A Form of Product Addendum...Master Manufacturing and Supply Agreement • May 5th, 2020 • New York
THIS MASTER MANUFACTURING AND SUPPLY AGREEMENT dated as of October 1, 2012 (the “Effective Date”) is made by and between Pfizer Inc., a corporation organized and existing under the laws of the State of Delaware, with offices at 235 East 42nd Street, New York, NY 10017 (hereinafter “Pfizer”) and Zoetis Inc., a corporation organized and existing under the laws of the State of Delaware, with offices at c/o Pfizer Inc. 235 East 42nd Street, New York, NY 10017 (hereinafter “Zoetis”). Pfizer and Zoetis may be referred to herein individually as a “Party” or collectively as the “Parties”.
MASTER MANUFACTURING AND SUPPLY AGREEMENTMaster Manufacturing and Supply Agreement • March 31st, 2009 • Response Biomedical Corp • Services-testing laboratories • New York
THIS MASTER MANUFACTURING AND SUPPLY AGREEMENT (“Master Agreement”) dated November 30, 2006 (“Effective Date”) is between 3M Company acting through its Medical Division (“3M”) and Response Biomedical Corporation, 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada (“RBC”). 3M and RBC are referred to jointly as “Parties” and individually as a “Party”.
EXHIBIT 10.25 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MASTER MANUFACTURING AND SUPPLY AGREEMENT This Master Manufacturing and Supply Agreement (this "Agreement") is...Master Manufacturing and Supply Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
MASTER MANUFACTURING AND SUPPLY AGREEMENT BETWEEN XenoPort, Inc., AND Patheon Pharmaceuticals Inc., DATED AS OF September 25, 2013.Master Manufacturing and Supply Agreement • November 8th, 2013 • Xenoport Inc • Pharmaceutical preparations
This MASTER MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) effective as of September 25, 2013 (the “Effective Date”) between XenoPort, Inc., a Delaware corporation having a principal place of business located at 3410 Central Expressway, Santa Clara, CA 95051 (“XenoPort”) and Patheon Pharmaceuticals Inc., a Delaware corporation having a principal place of business at 2110 E. Galbraith Road, Cincinnati, Ohio 45237-1625 (“Patheon”). XenoPort and Patheon are sometimes referred to herein individually as a “Party” and collectively as “Parties.”
MASTER MANUFACTURING AND SUPPLY AGREEMENTMaster Manufacturing and Supply Agreement • September 25th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations
This master manufacturing and supply agreement with its exhibits (“Agreement”) is made effective as of 19 September, 2019 (“Effective Date”) by and between:
Certain confidential information contained in this exhibit have been omitted by means of redacting a portion of the text and replacing it with [***], pursuant to Regulation S-K Item 601(b) of the Securities Act of 1933, as amended. Certain...Master Manufacturing and Supply Agreement • May 16th, 2022 • Novan, Inc. • Pharmaceutical preparations • Delaware
This Master Manufacturing and Supply Agreement is entered into as of the 16th day of August, 2018 (“Effective Date”) by and between Allergan Sales, LLC (“Allergan”), a Delaware limited liability company, and DPT Laboratories, Ltd. (“Contractor”), a Texas limited partnership (the “Agreement”). The Parties agree that the Agreement is entered into on behalf of the Parties and their respective Affiliates.
